文献速递烧伤创面修复

烧伤后急性肾损伤的综述

Acute kidney injury after burn.
PubMed 文献 · Burns · 2017-04-12

本文综述烧伤后急性肾损伤(AKI)的发生率与死亡率分别高达30%和80%,按KDIGO标准依据血肌酐和尿量分期,分为早期(伤后0-3天)和晚期(伤后4-14天),病因分别为低血容量、心肌抑制、变性蛋白沉淀与脓毒症、多器官衰竭、肾毒性药物,诊断困难且缺乏有效药物,肾脏替代治疗可改善预后。

要点

  • 烧伤后AKI发生率和死亡率可高达30%和80%。
  • 早期AKI(0-3天)多因低血容量、TNF-α心肌抑制等,晚期(4-14天)多因脓毒症等。
  • 肾脏替代治疗应早期启动,尚无有效药物,存活者多数不需长期透析。

核心结论

  • 烧伤后AKI常见且病死率高,需早期识别并针对病因干预,肾脏替代治疗可改善预后。

研究设计与样本

  • 本文为综述,未报告系统检索范围与样本量。

主要发现

  • 烧伤后AKI发生率和死亡率分别高达30%和80%。
  • 早期AKI(伤后0-3天)病因包括低血容量、肾灌注不足、TNF-α直接心肌抑制和变性蛋白沉淀。
  • 晚期AKI(伤后4-14天)常由脓毒症、多器官衰竭和肾毒性药物引起。
  • 即使存在显著肾损伤,尿量和生化标志物仍可相对正常,诊断困难。
  • 初步数据提示AKI可能增加终末期肾病和长期全因死亡风险,需进一步研究。

关键数值与推荐

  • KDIGO共识指南依据血肌酐和尿量随时间的变化定义AKI分期和严重程度。
  • 烧伤相关肾损伤分为早期(伤后0-3天)和晚期(伤后4-14天)。

临床怎么用

  • 首先逆转AKI的根本病因。
  • 若初始处理后损伤仍进展,应早期启动肾脏替代治疗。
  • 目前尚无证实有益的药物治疗。
  • 存活AKI的烧伤患者绝大多数不需长期血液透析,但需关注远期肾病风险。

局限性

  • 缺乏敏感特异的早期诊断生物标志物,多个候选标志物仍在研究中。
  • AKI增加终末期肾病和长期死亡风险的数据仅为初步,需进一步研究。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Acute kidney injury (AKI) is a common and morbid complication after severe burn, with an incidence and mortality as high as 30% and 80%, respectively. AKI is a broad clinical condition with many etiologies, which makes definition and diagnosis challenging. The most recent Kidney Disease: Improving Global Outcomes (KDIGO) consensus guidelines defined stage and severity of AKI based on changes of serum creatinine and urine output (UOP) across time. Burn-related kidney injury is typically classified as early (0-3days after injury) or late (4-14days after injury). Early burn AKI is typically due to hypovolemia, poor renal perfusion, direct cardiac suppression from TNF-alpha, and precipitation of denatured proteins, while late AKI is often due to sepsis, multi-organ failure, and nephrotoxic drugs. Diagnosis can be difficult as UOP and biochemical markers can be relatively normal even with significant renal injury. A sensitive and specific biomarker for the early diagnosis of AKI is sorely needed, and multiple potential biomarkers are being investigated. For treatment, the reversal of the underlying cause is the first intervention. The advent of renal replacement therapy has significantly improved the mortality of burn patients with AKI and should be initiated early if injury progresses despite initial maneuvers. Unfortunately, no beneficial pharmacologic agents have been identified, despite multiple investigations. Of burn patients who survive AKI, the vast majority do not receive long-term hemodialysis and they are generally thought to have a good renal prognosis although this view is shifting. Preliminary data in the burn population suggest that AKI may confer an increased risk of end-stage renal disease and long-term all-cause mortality, but further research is needed.

来源:Burns,查看原文。版权归原作者所有。

引用

  1. Clark A, Neyra JA, Madni T, et al. Acute kidney injury after burn. Burns. 2017. PMID: 28412129. doi:10.1016/j.burns.2017.01.023

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。